Skip to content
Making A Social Contract That’s Enforceable episode artwork

Mar 12, 2020 45 min

Making A Social Contract That’s Enforceable

from The Bio Report Hosted by Levine Media Group

As the debate over drug pricing intensifies, biotech investor Peter Kolchinsky is weighing in with a proposed approach to balance access to medicines with the incentive for companies to invest in the development of innovative new therapies. In his new book The Great American Drug Deal, Kolchinsky makes the case for an approach to drug pricing that would ensure that the timely movement of innovative drugs to generic versions while also suggesting mechanisms for cutting the price of therapeutics after patents and exclusivity periods expire when competition fails to arise. We spoke to Kolchinsky about The Great American Drug Deal, his notion of a biotech social contract, and why it’s critical that the industry think differently than it has in the past about approaches to reform drug pricing.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Making A Social Contract That’s Enforceable

0:00 45:05

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The Bio Report?

This episode is 45 minutes long.

When was this The Bio Report episode published?

This episode was published on March 12, 2020.

Can I download this The Bio Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.